ArticlePloS one2025
SpaVGN: A hybrid deep learning framework for high-resolution spatial transcriptomics data reconstruction and spatial domain identification.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spatial transcriptomics has revolutionized the analysis of gene expression while preserving tissue spatial information, which provides novel insights into the cellular composition and function of complex biological tissues. However, current technologies are constrained by limited resolution and data sparsity, compromising the accuracy of downstream analyses. To address these challenges, we developed SpaVGN, a deep learning framework integrating convolutional neural networks, vision transformer, and graph neural networks for high-fidelity gene expression imputation and spatial domain identification. By combining local feature extraction, global attention mechanisms, and spatial graph-based modeling, SpaVGN effectively reconstructs missing transcriptomic data while preserving spatial tissue architecture. Evaluated on melanoma and sagittal posterior mouse brain datasets, SpaVGN outperformed existing methods in gene expression prediction, achieving Pearson correlation coefficients of 0.609 (melanoma) and 0.682 (mouse brain). It clearly delineated tumor regions and lymphoid niches in melanoma tissue, achieving fine-grained resolution of hippocampal subfields, including Cornu Ammonis and Dentate Gyrus, with a Silhouette Score of 0.43 and a Davies-Bouldin Index of 0.86. Validation through UMAP dimensionality reduction and PAGA network analysis demonstrated that SpaVGN significantly mitigates the negative impact of data sparsity in spatial transcriptomics, improving data completeness and spatial continuity. This study presents an innovative solution that enhances the resolution of spatial transcriptomics data, offering cross-tissue applicability and providing a valuable tool for research in biological development, disease, and tumor heterogeneity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.